• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New UCI study reveals brain circuit responsible for cocaine withdrawal-induced anxiety and relapse-related behavior

Bioengineer by Bioengineer
May 3, 2022
in Health
Reading Time: 3 mins read
0
Brain circuit responsible for withdrawal and relapse behaviors
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Irvine, CA – May 3, 2022 – New research from the University of California, Irvine, finds that drug withdrawal-induced anxiety and reinstatement of drug seeking behaviors are controlled by a single pathway in the brain and centered around dopamine cells.

Brain circuit responsible for withdrawal and relapse behaviors

Credit: UCI School of Medicine

Irvine, CA – May 3, 2022 – New research from the University of California, Irvine, finds that drug withdrawal-induced anxiety and reinstatement of drug seeking behaviors are controlled by a single pathway in the brain and centered around dopamine cells.

The study, “An extended amygdala-midbrain circuit controlling cocaine withdrawal-induced anxiety and reinstatement,” was published today in Cell Reports.

Addiction occurs in phases: initial drug exposures are rewarding, repeated administration leads to tolerance or sensitization to the drug’s effects, and withdrawal leads to anxiety and a negative affective state, which, in turn, contribute to reinstatement of drug taking/seeking.

 “In order to prevent relapse among drug users, specifically cocaine users, we need to understand the factors in the brain that contribute to drug seeking behaviors and the vulnerability to relapse,” said Kevin Beier, PhD, assistant professor of physiology and biophysics at UCI School of Medicine. “In this study, we identified a brain circuit that is responsible for drug withdrawal-induced anxiety as well as relapse-related behavior, along with the identification of a potential target for therapeutic interventions.”

The negative affective state induced by withdrawal from use of drugs of abuse is a critical factor causing drug users to relapse.

“Both the drug withdrawal-induced anxiety and reinstatement of drug seeking are controlled by a single pathway centered around dopamine cells in the ventral midbrain,” explained Beier. “That a single pathway controls both sets of behavioral changes may help to explain many addiction-related behavioral phenomena. Importantly, it links them both directly to dopamine, which is more typically linked to reward-related behaviors.”

Although midbrain dopamine circuits are central to motivated behaviors, the knowledge of how experience modifies these circuits to facilitate subsequent behavioral adaptations is limited. This study demonstrates the selective role of a ventral tegmental area dopamine projection to the amygdala for cocaine induced anxiety, but not cocaine reward or sensitization. Silencing this projection prevents development of anxiety during protracted withdrawal after cocaine use.

According to the National Center for Drug Abuse Statistics, there are roughly 70,000 drug overdoses each year in the United States.  In 2017, nearly one in five drug overdose deaths was cocaine-related, with the highest rate of cocaine-related overdoses and deaths occurring among non-Hispanic black populations. Between 2012 and 2018, the rate of cocaine-related overdose deaths increased from 1.4 to 4.5 percent. The American Addiction Centers state recent drug relapse statistics show that more than 85 percent of individuals relapse and return to drug use within a year following treatment.

This work was supported by the National Institutes of Health, Tobacco-Related Disease Research Program, American Parkinson Disease Association, Alzheimer’s Association, New Vision Research, and the Brain and Behavior Research Foundation.

About the UCI School of Medicine: Each year, the UCI School of Medicine educates more than 400 medical students, and nearly 150 doctoral and master’s students. More than 700 residents and fellows are trained at UCI Medical Center and affiliated institutions. The School of Medicine offers an MD; a dual MD/PhD medical scientist training program; and PhDs and master’s degrees in anatomy and neurobiology, biomedical sciences, genetic counseling, epidemiology, environmental health sciences, pathology, pharmacology, physiology and biophysics, and translational sciences. Medical students also may pursue an MD/MBA, an MD/master’s in public health, or an MD/master’s degree through one of three mission-based programs: Health Education to Advance Leaders in Integrative Medicine (HEAL-IM), Leadership Education to Advance Diversity-African, Black and Caribbean (LEAD-ABC), and the Program in Medical Education for the Latino Community (PRIME-LC). The UCI School of Medicine is accredited by the Liaison Committee on Medical Accreditation and ranks among the top 50 nationwide for research. For more information, visit som.uci.edu.



Journal

Cell Reports

DOI

10.1016/j.celrep.2022.110775

Subject of Research

People

Article Title

An extended amygdala-midbrain circuit controlling cocaine withdrawal-induced anxiety and reinstatement

Article Publication Date

3-May-2022

COI Statement

The authors declare no competing interests.

Share12Tweet8Share2ShareShareShare2

Related Posts

AP3B1 and BMPR2: New Parkinson’s Blood Biomarkers

October 28, 2025

Exploring Nurses’ Commitment: Impact of Job and Life Satisfaction

October 28, 2025

Adolescent 22q11.2 Deletion Syndrome: Hypergonadotropic Hypogonadism Explored

October 28, 2025

Houseplant-Inspired Textured Surfaces Combat Copper IUD Corrosion

October 28, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1288 shares
    Share 514 Tweet 322
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    310 shares
    Share 124 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    198 shares
    Share 79 Tweet 50
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    135 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

AP3B1 and BMPR2: New Parkinson’s Blood Biomarkers

Exploring Nurses’ Commitment: Impact of Job and Life Satisfaction

Ovine Toxoplasmosis Risks Uncovered in Iraq Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.